Rules of Origin for medical devices (needles, catheters) — Dubai (UAE) to India
HS 90183900 · Medical devices · Rules of Origin & preferential rate
Data last updated: · MFN duty & IGST verified against ICEGATE (Indian Customs EDI). Rules of Origin per CEPA Annex 3B. Verify your exact HS line before filing.
No CEPA benefit
This line is excluded from India's India–UAE CEPA tariff offer, so the 7.5% MFN basic customs duty applies regardless of origin. The goods are normally importable — there is simply no preferential rate to claim.
- CEPA eligible
- Excluded
- Value addition (RVC)
- 40%
- Tariff-classification change
- CTSH Annex 3B rule set at chapter level — it covers the whole chapter, not this code alone
- MFN → CEPA basic duty
- 7.5% → 7.5%
Rule of Origin (CEPA Annex 3B, primary source): Chapter 90: CTSH + VA 40% (origin rule; many devices excluded from India's tariff offer)
Qualifying under the Rules of Origin
Medical devices (needles, catheters) (HS 90183900) is currently excluded from India's India–UAE CEPA tariff offer, so no preferential rate applies regardless of origin. For reference, the Product-Specific Rule for this line is "Chapter 90: CTSH + VA 40% (origin rule; many devices excluded from India's tariff offer)". Read that rule for what it is: Annex 3B supplies it at chapter level, so it governs hundreds of eight-digit codes rather than this one. It is the correct rule to apply, and it is also the place to check for a more specific carve-out before committing to a claim. Needles, catheters and cannulae are high-volume consumables for Indian hospitals, and demand grows with insurance-backed procedure volumes. Medical devices carry a far heavier regulatory load than tariff: CDSCO import licensing under the Medical Device Rules, risk-class determination, and an authorised Indian agent are all prerequisites, and clearance turns on that registration rather than on origin. Sterile single-use devices additionally need batch-level sterilisation records. Confirm the device's risk class before contracting, because the licence pathway and timeline differ sharply between classes and a CEPA claim cannot substitute for the registration. One caveat on the duty position itself: this is an HS-2022 code with no direct line in Annex 2A, and the HS-2017 siblings beneath the heading are split between a phased concession and outright exclusion, so the conservative reading stands here. Because the line is excluded, customs charges the 7.5% MFN rate. Confirm eligibility against India's CEPA tariff schedule before assuming any benefit.
Check your own figures in the Rules of Origin (RVC) qualifier. Qualifying is only half of it — the preference is claimed with a Certificate of Origin, issued in the UAE before shipment or retrospectively within 12 months.
Frequently asked questions
- Does medical devices (needles, catheters) qualify for India–UAE CEPA?
- No — this line is currently excluded from India's CEPA tariff offer, so the preferential rate does not apply regardless of origin.
- What is the Rule of Origin for medical devices (needles, catheters)?
- Per CEPA Annex 3B: Chapter 90: CTSH + VA 40% (origin rule; many devices excluded from India's tariff offer). RVC% = [(FOB − value of non-originating materials) / FOB] × 100 (FOB basis).
- What proof is needed at import?
- A preferential Certificate of Origin filed through eCoO 2.0, presented at customs before clearance. Without it, the 7.5% MFN duty applies.